Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States

PURPOSE: There is limited literature regarding real-world treatment patterns of patients with COPD, particularly since the introduction of once-daily single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol in 2017. Here, we evaluated treatment patterns of patients with COPD be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogart, Michael, Germain, Guillaume, Laliberté, François, Lejeune, Dominique, Duh, Mei Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377554/
https://www.ncbi.nlm.nih.gov/pubmed/37521022
http://dx.doi.org/10.2147/COPD.S398816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377554/
https://www.ncbi.nlm.nih.gov/pubmed/37521022
http://dx.doi.org/10.2147/COPD.S398816

Ejemplares similares